Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LaValle Healthcare awaiting DSHEA clarification before launching into supplement trade.

This article was originally published in The Tan Sheet

Executive Summary

LAVALLE HEALTHCARE AWAITING DIETARY SUPPLEMENT LAW CLARIFICATION before marketing herbal or nutritional supplements, the homeo-pathic treatments firm said. The company has considered entering the marketplace with an herbal or nutritional supplement, but decided to avoid the complications of trying to make claims for the products until the Dietary Supplement Health & Education Act governing the products is further clarified, the company said, claiming "homeopaths want regulation" of products.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086270

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel